Abstract:Capillary electrophoresis coupled with tandem mass spectrometry (CE-MS/MS) offers advantages in peak capacity and sensitivity for metabolic profiling, owing to the electroosmotic flow-based separation. However, the utilization of data-independent MS/MS acquisition (DIA) is restricted due to the absence of an optimal procedure for analytical chemistry and its related informatics framework. We assessed the mass spectral quality using two DIA techniques, namely, all-ion fragmentation (AIF) and variable DIA (vDIA), to isolate 60∼800 Da precursor ions with respect to annotation rates. Our findings indicate that vDIA, coupled with the updated MS-DIAL chromatogram deconvolution algorithm, yields higher spectral matching scores and annotation rates compared to AIF. Additionally, we evaluated a linear migration time (MT) correction method using internal standards to accurately align chromatographic peaks in a dataset. After the correction, the peaks exhibited less than 0.1 min MT drifts, a difference mostly equivalent to that of conventional reverse-phase liquid chromatography techniques. Moreover, we conducted MT prediction for metabolites recorded in mass spectral libraries and metabolite structure databases containing a total of 469,870 compounds, achieving an accuracy of less than 1.5 min root mean squares. Thus, our platform provides a peak annotation platform utilizing MT information, accurate precursor , and the MS/MS spectrum recommended by the metabolomics standards initiative. Applying this procedure, we investigated metabolic alterations in lipopolysaccharide (LPS)-induced macrophages, characterizing 170 metabolites. Furthermore, we assigned metabolite information to unannotated peaks using an structure elucidation tool, MS-FINDER. The results were integrated into the nodes in the molecular spectrum network based on the MS/MS similarity score. Consequently, we identified a significantly increased amount of metabolites in the LPS-administration group, glycinamide ribonucleotide, not present in any spectral libraries. Additionally, we retrieved metabolites of false-negative hits in the initial spectral annotation procedure. Overall, our study underscores the potential of CE-MS/MS with DIA and computational mass spectrometry techniques for metabolic profiling.

Evaluation of Data-Dependent MS/MS Acquisition Parameters for Non-Targeted Metabolomics and Molecular Networking of Environmental Samples: Focus on the Q Exactive Platform

Optimization of Mass Spectrometric Parameters in Data Dependent Acquisition for Untargeted Metabolomics on the Basis of Putative Assignments

Improving the Data Quality of Untargeted Metabolomics through a Targeted Data-Dependent Acquisition Based on an Inclusion List of Differential and Preidentified Ions

Comparing Targeted vs. Untargeted MS2 Data-Dependent Acquisition for Peak Annotation in LC–MS Metabolomics

Rapid Development of Improved Data-Dependent Acquisition Strategies

Eight key rules for successful data‐dependent acquisition in mass spectrometry‐based metabolomics

MetaboMSDIA: A tool for implementing data-independent acquisition in metabolomic-based mass spectrometry analysis

Comparative Evaluation of Data Dependent and Data Independent Acquisition Workflows Implemented on an Orbitrap Fusion for Untargeted Metabolomics

Evaluation of significant features discovered from different data acquisition modes in mass spectrometry-based untargeted metabolomics

Evaluation of Nontargeted Mass Spectral Data Acquisition Strategies for Water Analysis and Toxicity-Based Feature Prioritization by MS2Tox

Using variable data independent acquisition for capillary electrophoresis-based untargeted metabolomics

Advancing untargeted metabolomics using data-independent acquisition mass spectrometry technology

Development of data-independent acquisition workflows for metabolomic analysis on a quadrupole-orbitrap platform

Development of a GC/Quadrupole-Orbitrap Mass Spectrometer, Part II: New Approaches for Discovery Metabolomics

Evaluation of GC-APCI/MS and GC-FID as a complementary platform.

Towards Unbiased Evaluation of Ionization Performance in LC-HRMS Metabolomics Method Development

Best practices for experimentation and reporting in 1 mass spectrometry based metabolomics 2

Is nontargeted data acquisition for target analysis (nDATA) in mass spectrometry a forward-thinking analytical approach?

Advances in mass spectrometry applied to pharmaceutical metabolomics

Theory and Instrumentation of Mass Spectrometry and its Application to Drug Metabolism

Evaluation of Acquisition Modes for Semi‐Quantitative Analysis by Targeted and Untargeted Mass Spectrometry